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Objective: The gut microbiota contribute otherwise impossible metabolic functions to the human host. Shifts in the relative
proportions of gut microbial communities in adults have been correlated with intestinal disease and have been associated with
obesity. The aim of this study was to elucidate differences in gut microbial compositions and metabolite concentrations of obese
versus normal-weight children.
Materials and methods: Fecal samples were obtained from obese (n¼15; mean body mass index (BMI) s.d. score¼1.95) and
normal-weight (n¼15; BMI s.d. score¼ 0.14) Swiss children aged 8–14 years. Composition and diversity of gut microbiota
were analyzed by qPCR and temperature gradient gel electrophoresis (TGGE).
Results: No significant quantitative differences in gut microbiota communities of obese and normal-weight children were
identified. Microbial community profiling by TGGE revealed a high degree of both intra- and intergroup variation. Intergroup
comparison of TGGE profiles failed to identify any distinct populations exclusive to either obese or normal-weight children.
High-pressure liquid chromatography analysis identified significantly higher (Po0.05) concentrations of short-chain fatty acids
(SCFA) butyrate and propionate in obese versus normal-weight children. Significantly lower concentrations of intermediate
metabolites were detected in obese children, suggesting exhaustive substrate utilization by obese gut microbiota.
Conclusions: Our results indicate that a dysbiosis may be involved in the etiology of childhood obesity. In turn, aberrant and
overactive metabolic activity within the intestine could dictate survival or loss of individual microbial communities, leading to
the altered population ratios previously identified in adult obesity.
Nutrition and Diabetes (2011) 1, e12; doi:10.1038/nutd.2011.8; published online 18 July 2011
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Introduction
The human gut is home to over 1 trillion microbes,
collectively referred to as the gut microbiota. Dominated
by anaerobic bacteria, the gut microbiota provide essential
metabolic capacities to humans, negating the necessity for
human evolution of these traits. Maintenance of the delicate
gut microbiota balance creates a beneficial symbiotic
relationship responsible for dietary energy extraction,
attenuation of infection and inflammation, as well as a
multitude of other processes.
1,2 16S rRNA-Based sequencing
techniques have implied changes to this delicate balance of
gut microbiota, which may potentially contribute to devel-
opment of several pathological conditions (e.g., irritable
bowel disease) or metabolic diseases such as obesity.
3–6 About
90% of the gut microbial community is dominated by
members of the Bacteroidetes and Firmicutes phyla, and an
increased ratio of Firmicutes to Bacteroidetes has been
implicated in the development of adult obesity.
4,7–10 Other
attempts in correlating obesity to changes in individual gut
microbiota communities have been unsuccessful, countering
that metabolic activity and not composition of the gut
microbiota might be more relevant in the development of
obesity.
10,11 Although the definitive contribution of the gut
microbiota to obesity remains largely debated, metabolic
analyses of obese and normal-weight adult feces have indeed Received 20 January 2011; revised 8 April 2011; accepted 23 May 2011
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tions in obese individuals.
11 Microbial fermentation of
hydrolyzed polysaccharides in the large intestine results in
production of SCFA acetate, propionate and butyrate;
branched chain fatty acids; lactate, formate, ethanol and
mixed gases (e.g., CH4,C O 2 and H2).
12 SCFA resulting from
colonic fermentation may provide an estimated additional
10% daily dietary energy to the host, which may be used for
de novo hepatic triglyceride and glucose synthesis.
13–16
Hence, a mere daily energy increase of 1%, providing an
additional 20kcal per day, based on a 2000kcal per day diet,
could result in nearly 1kg of weight gain annually.
The aim of this study was to examine the gut microbial
compositions and fecal metabolite concentrations of obese
and normal-weight children. Fecal samples were obtained
from obese (n¼15; mean body mass index (BMI) s.d.
score¼1.95) and normal-weight (n¼15; mean BMI s.d.
score¼ 0.14) Swiss children aged 8–14 years and analyzed
for differences in both community composition and meta-
bolite concentrations. Individual microbial populations were
quantitatively evaluated by qPCR. Temperature gradient gel
electrophoresis (TGGE) was used to profile the intra- and
intergroup diversity of obese and normal-weight gut micro-
biota. Fecal metabolite concentrations were measured using
high-pressure liquid chromatography (HPLC).
Materials and methods
Study population
The primary interest of our study was to generate a random
cohort of obese and normal-weight children from their daily,
routine environments. Obese (n¼15; mean BMI s.d.
score¼1.95) and normal-weight (n¼15; mean BMI s.d.
score¼ 0.14) Swiss children aged 8–14 years, who had not
been exposed to antibiotic treatment for the past 3 months,
were recruited for this study. The children were classified as
obese or normal-weight, based on gender- and age-specific
BMI percentiles from the Centers for Disease Control (http://
www.cdc.gov), in which obesity is defined as X95th
percentile and normal-weight defined as o85th percentile.
The obese children were recruited from the obesity counsel-
ing center at the Ostschweizer Kinderspital in St. Gallen,
Switzerland and included nine boys and six girls (Table 1).
Normal-weight children were recruited from primary schools
in the area and included eight boys and seven girls (Table 1).
All the children were Caucasian and long-term residents of
Switzerland. Dietary intakes were not controlled for in this
study. A brief baseline assessment of dietary intakes was
performed using a short dietary questionnaire. Children in
both groups were determined to consume comparable diets
typical of northern Switzerland. Children’s diets in this area
typically contain 34–36% of energy as fat, 14–16% of energy
as protein, with the main energy sources being bread, dairy
and meat products.
17 No food allergies were reported in
either group and only two children reported altered eating
habits with one obese child never consuming fish and one
normal-weight child abstaining from dairy products. Life-
style data pertaining to physical activity was not obtained.
The parents of the children gave informed written consent,
and the children assented to the study. The study was
approved by both the ETH (EK 2009-N-01) and the canton of
St. Gallen Ethics Committees (EKSG09/157/1B).
Fecal sample collection and storage
Fresh fecal samples were deposited in sterile plastic contain-
ers (Dutscher SA, Brumath, France). Containers were
maintained under anaerobiosis by use of anaerobic sacks
(Anaerocult A mini, Merck KGaA, Darmstadt, Germany).
Fecal samples were delivered to the laboratory and aliquoted
into sterile Eppendorf tubes (Vaudaux-Eppendorf AG, Basel,
Switzerland) before storage at  801C. The entire process
from defecation to storage did not exceed 2h.
Bacterial strains and culture conditions
Roseburia intestinalis (DSM 14610) and Blautia hansenii
(DSM 20583) were purchased from German Collection of
Microorganisms and Cell Cultures (DSMZ, Braunschweig,
Germany). Escherichia coli (ATCC 25288), Bacteroides fragilis
(ATCC 25285T), Bifidobacterium longum (ATCC 15707) and
Lactobacillus rhamnosus GG (ATCC 53103) were obtained
from American Type Culture Collection (ATCC; Manassas,
VA, USA). Anaerobic culture methods were used with O2-free
CO2-sparged Hungate tubes sealed with butyl-rubber stop-
pers (Dutscher SA, Brumath, France) for cultivation of
R. intestinalis, B. hansenii, B. fragilis, B. longum and L. GG.
18
Strains were grown at 371C in 10ml yeast extract-casitone-
fatty acid media supplemented with 2% each D-glucose and
soluble starch (Sigma, Buchs, Switzerland) as previously
described.
19 E. coli was grown aerobically overnight at 371C
in Luria–Bertani broth.
Nucleic acid extraction
DNA was extracted from 250mg feces using the FastDNA
Spin Kit for Soil (Qbiogene AG, Basel, Switzerland) and
quantified using the Nanodrop ND-1000 spectrophotometer
(Witec AG, Littau, Switzerland) at 260nm.
Table 1 Characteristics of obese and normal-weight children in this study
Obese Normal-weight
Subjects (male/female) 15 (9/6) 15 (8/7)
Age (years) 10.6±1.3 10.0±1.4
BMI (kgm
 2) 25.5±3.3 16.8±1.8
BMI s.d. score 1.95±0.3  0.14±0.7
Abbreviations: BMI, body mass index; s.d., standard deviation. Data are
shown as mean±s.e.
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Amplification and detection of DNA by qPCR was performed
with a 7500 Fast Real-Time PCR System (Applied Biosystems
Europe BV, Zug, Switzerland) using optical-grade 96-well
plates. Duplicate sample analysis was routinely performed in
a total volume of 25ml using SYBR Green PCR Master Mix
(Applied Biosystems) containing 200nM of both forward and
reverse primers (Table 2). Standard curves were routinely
performed for each qPCR run using serial dilutions of control
DNA (Table 2). PCR conditions consisted of initial activation at
951C for 10min; 40 cycles of denaturation at 951Cf o r1 5 s ,
annealing at 601C for 30s and elongation at 601Cf o r3 0 s .
Data from duplicate samples were analyzed using the Sequence
Detection Software Version 1.4 (Applied Biosystems).
PCR Amplification of 16S rRNA
DNA (100ngml
 1) was used to PCR amplify the variable
V2-V3 16S rRNA gene sequence using universal primers
HDA-1GC (CGCCCGGGGCGCGCCCCGGGCGGGGCGGG
GGCACGG GGGGACTCCTACGGGAGGCAGCAGT) and
HDA-2 (GTATTACCGCGGCTGCTGGCAC) and a modified
protocol of Ogier et al.
20 PCR reactions consisted of 2 
Fermentas PCR Mastermix (1  PCR buffer, 2mM MgCl2,
0.2mM each dNTP and 1U Taq polymerase) diluted 1:1 with
sterile ultra-pure water (Millipore AG, Zug, Switzerland).
Samples were amplified on a Biometra Personal Cycler
(Biometra, Cha ˆtel-St.Denis, Switzerland). Reaction condi-
tions were as follows: 941C for 5min; 35 cycles of 941C for
3min, 581C for 30s, 681C for 1min and finally 681C for
7min.
TGGE analysis of PCR amplicons
TGGE gels (16cm 16cm 1mm) were composed of 6%
acrylamide/bis-acrylamide (37.5:1). (Sigma), 7 M urea (Sigma)
and 1.5 Tris-acetate-EDTA buffer.
21 TGGE was performed
with 50ng 16S rRNA PCR amplicons using a Dcode universal
mutation system (Bio-Rad, Reinach, Switzerland). A custom
marker was created by mixing equal concentrations of 16S
rRNA PCR amplicons of B. fragilis, E. coli, R. intestinalis,
B. hansenii, B. longum and L. rhamnosus GG. Electrophoresis
conditions included a pre-run of 20min at 20V followed by
16h at 70V in 1.5 Tris-acetate-EDTA buffer. Temperature
was increased from 661Ct o7 0 1C using a ramp rate of
0.41Cmin
 1. Gels were stained for 30min in ethidium
bromide and destained for 1h in dH2O before imaging.
Metabolite analysis by high-pressure liquid chromatography
SCFA, branched chain fatty acids and intermediate metabo-
lites were determined by HPLC as previously described.
22
Mean metabolite concentrations of fecal samples were
calculated from duplicate sample analysis.
Statistical analysis
Mean copy numbers were transformed to their base 10
logarithmic values for variance homogeneity. One-way
analysis of variance was performed to test effects of
weight status on bacterial populations and SCFA production
using JMP 8.0 (SAS Institute Inc., Cary, NC, USA). When
significant differences were found below Po0.05, treatment
means were compared using the Tukey–Kramer HSD test.
Table 2 Group and species-specific 16S rRNA gene-targeted primers used in this study
Target organism 50–30 Sequence Primer Standard Reference
All bacteria ACTCCTACGGGAGGCAGCAG Eub 338F pLME21 41
ATTACCGCGGCTGCTGG Eub 518R
Bacteroides GAAGGTCCCCCACATTG Bac303F B. thetaiotaomicron 16S rRNA 42
CGCKACTTGGCTGGTTCAG Bfr-Femrev
Firmicutes GGAGYATGTGGTTTAATTCGAAGCA Firm934F R. intestinalis 16S rRNA 41
AGCTGACGACAACCATGCAC Firm1060R
Roseburia/E. rectale GCGGTRCGGCAAGTCTGA RrecF R. intestinalis 16S rRNA 42
CCTCCGACACTCTAGTMCGAC Rrec630mR
Lactobacillus AGCAGTAGGGAATCTTCCA F_Lacto 05 L. delbrueckii 16S rRNA 43
CGCCACTGGTGTTCYTCCATATA R_Lacto 04
Bifidobacterium ATCTTCGGACCBGAYGAGAC xfp-fw xfp amplicon 44
phosphoketolase CGATVACGTGVACGAAGGAC xfp-rv
Enterobacteriaceae CATTGACGTTACCCGCAGAAGAAGC Eco1457F E.coli 16S rRNA 45
CTCTACGAGACTCAAGCTTGC Eco1652R
F. prausnitzii GGAGGAAGAAGGTCTTCGG FPR-2F F. prausnitzii 16S rRNA 42
AATTCCGCCTACCTCTGCACT Fprau645R
Sulfate-reducing bacteria CGGCGTTGCGCATTTYCAYACVVT dsrA_290F D. piger dsrA 46
GCCGGACGATGCAGHTCRTCCTGRWA dsrA_660R
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Comparative analysis of gut microbiota communities in obese
and normal-weight children
qPCR was performed to quantitatively assess individual gut
microbial populations in obese and normal-weight children.
Numerical variations in population numbers measured
between obese and normal-weight children were not statis-
tically significant for any population tested (Table 3).
Comparative analysis of both Firmicutes and Bacteroides,a
major genus of the Bacteroidetes phylum, indicated no
correlation between an elevated Firmicutes/Bacteroidetes ratio
and childhood obesity. The Firmicutes/Bacteroides ratio was
nearly 1:1 in obese children, whereas normal-weight chil-
dren demonstrated a higher Bacteroides/Firmicutes ratio. The
butyrate-producing Roseburia/E. rectale population of Clos-
tridia cluster XIVa was over 1 log higher in both obese and
normal-weight children compared with the cluster IV
butyrate-producer F. prausnitzii (Table 3). Sulfate-reducing
bacteria (SRB) displayed the highest level of individual
variation demonstrated by the high s.d.’s of 1.4 and 1.3 for
obese and normal-weight children, respectively, (Table 3)
and with individual populations ranging from o3.0 log10
copies–1g to 8.0 log10 copies–1g.
Microbial community profiling of obese and normal-weight
children
Microbial community profiles of each obese and normal-
weight volunteer were assessed by TGGE (Supplementary
Figures 1 and 2). TGGE is routinely used to analyze the
diversity of complex biological samples by identifying 16S
rRNA sequence heterogeneities. Visual inspection of TGGE
profiles of both obese and normal-weight children revealed
an obvious and highly variable microbial diversity between
volunteers, illustrated by the highly random banding
patterns of each individual microbiota (Supplementary
Figures 1 and 2). Samples from a small number of volunteers
were difficult to resolve by TGGE, despite multiple DNA
extractions and PCR amplification attempts and is attributed
to the co-extraction of PCR inhibitors during DNA extraction
(Supplementary Figure 2, lanes 5, 6 and 10). Furthermore,
pooling multiple PCR amplifications also did not improve
the resolution of these samples, as the maximum loading
capacity of each well was limited to 60ml. The highly
individualized communities identified by TGGE suggest
microbial diversity is a function of host-specific factors,
which appear unrelated to weight status. No distinct
microbial communities could be ascribed as unique to either
group, suggesting caution in applying community profiling
to the search for a community-associated obesity marker.
Fecal SCFA concentration differences between obese and
normal-weight children
Concentrations of SCFA present in feces of obese
and normal-weight children were determined using HPLC
(Table 4). Fecal metabolite analyses represent endpoint
measurements of metabolic activity within the human large
intestine as both the number of active enteric bacteria in the
small intestine and the absence of SCFA ingested through
foods limit SCFA in the small intestine.
23 SCFA are produced
as a function of microbial fermentation of non-absorbed or
non-digestible carbohydrates with host metabolism of these
compounds occurring after epithelial uptake. Significantly
higher concentrations of butyrate and propionate (Po0.05)
were detected in obese (33.1mM and 29.2mM, respectively)
versus normal-weight children (25.3mM and 21.6mM,
respectively). Total SCFA concentrations were not statisti-
cally different. In general, large individual intragroup
variations were observed, with variation coefficients between
20 and 45% for metabolite concentrations and ratios.
Concentrations of acetate were similar between the two
groups (Table 4). Analysis of SCFA ratios revealed no
statistically relevant differences in acetate/butyrate, acetate/
propionate or butyrate/propionate ratios in obese and
normal-weight children. Ratios of individual SCFA/total
SCFA were also similar between both groups (Table 4).
Intermediate metabolites present in obese and normal-weight
children
Both the presence and concentrations of various intermedi-
ate metabolites were determined by HPLC (Table 5). Only
trace amounts of lactose were detected in both groups,
suggesting complete enzymatic hydrolysis of lactose to
glucose and galactose. Concentrations of the branched chain
fatty acids isovalerate were similar in obese (2.18mM) and
normal-weight children (3.05mM), whereas isobutyrate was
significantly higher in obese children (Table 5). Higher
concentrations of formate were detected in the obese group;
Table 3 Bacterial populations measured by qPCR in fecal samples from obese
(n¼15) and normal-weight children (n¼15)
Bacterial phylogeny
population
Obese Normal-weight P-value
log10
copies-1g
a
s.d. log10
copies-1g
a
s.d.
Eubacteria 10.8 ±0.9 10.7 ±0.6 0.61
Bacteroidetes
Bacteroides 9.8 ±0.5 10.0 ±0.6 0.34
Actinobacteria
Bifidobacterium 7.6 ±0.7 7.3 ±0.5 0.24
Proteobacteria
Enterobacteriaceae 8.1 ±1.2 7.7 ±0.4 0.20
Firmicutes 9.5 ±0.8 9.3 ±0.5 0.13
Firmicutes/bacilli
Lactobacillus 6.1 ±0.7 6.8 ±0.9 0.19
Firmicutes/clostridial cluster XIVa
Roseburia/E. rectale 9.8 ±0.6 9.4 ±0.6 0.26
Firmicutes/clostridial cluster IV
F. prausnitzii 8.4 ±0.6 7.9 ±0.9 0.19
Sulfate reducing bacteria 6.6 ±1.4 6.4 ±1.3 0.51
Abbreviation: s.d., standard deviations of the mean.
aData are mean
log10copies 16S rRNA/g feces.
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Concentrations of lactate were significantly higher in
normal-weight children (Po0.05). Valerate was also present
at significantly higher amounts (Po0.05) in normal-weight
subjects (Table 4). Residual amounts of glucose were detected
in both groups, with higher concentrations of glucose
(26.1mM) measured in normal-weight versus obese subjects
(4.55mM). However, the large s.d. calculated for the normal-
weight results (±61.71mM) suggests cautionary interpreta-
tion of these results. When glucose calculations were
corrected for by removal of several high outlying values,
both the mean and s.d. were reduced (3.3mM and 4.3mM,
respectively) and the difference between the obese and
normal-weight group became statistically insignificant.
Discussion
In the present study, we analyzed gut microbial composi-
tions and fecal metabolite concentrations in obese and
normal-weight children from a heterogeneous population
that included the majority of ethnicities present in German-
speaking Switzerland. Dietary intakes were not extensively
recorded and not controlled for in this study, as our goal was
to randomly sample obese and normal-weight children
exhibiting normal eating and lifestyle behavior. To our
knowledge, this represents the first description of the
composition and metabolite characterization of gut micro-
biota obtained from obese and normal-weight children
sampled without dietary restrictions or controls.
Community membership of gut microbiota from obese
and normal-weight children was highly similar. Of the
major microbial phyla and genera present in feces, no
significant quantitative differences in individual commu-
nities of obese and normal-weight gut microbiota could
be identified. Microbiota were predominately composed
of Firmicutes and Bacteroides. Roseburia/E. rectale, a member
of Clostridia cluster XIVa, represents a larger Firmicutes
subgroup in comparison with cluster IV of which
F. prausnitzii is a member. Hence, the higher proportion
of Roseburia/E. rectale/ F. prausnitzii detected in both
groups is expected. Although the Bacteroidetes phylum
comprises several genera in addition to Bacteroides, the
Bacteroides genus has been demonstrated to be one of
four major groups of adult microbiota.
24,25 In contrast to
adult studies in which a higher Firmicutes/Bacteroidetes
ratio has been proposed as relevant in the development of
obesity, no correlation of an increased Firmicutes/Bacteroides
ratio to childhood obesity could be established.
4,7–9
Community profiling of individual obese and normal-weight
subjects by TGGE illustrated highly variable and individual
biodiversity. Host-specific uniqueness in microbial
diversity was sufficiently demonstrated by TGGE profiling
and is in agreement with previously published reports.
26,27
Intergroup inspection of microbial diversity failed to
demonstrate any communities associated exclusively with
weight status.
Table 4 SCFA concentrations and ratios of fecal samples from obese and normal-weight children assessed by HPLC
Metabolite Obese Normal-weight P-value
mM
a s.d. % SCFA mM
a s.d. % SCFA
Total SCFA 142.8 ±28.6 100 124.9 ±31.5 100 0.09
Acetate 80.6 ±18.8 56.4 77.9 ±24.6 62.3 0.97
Butyrate 33.1 ±10.3 23.2 25.3 ±8.7 20.4 0.01*
Propionate 29.2 ±13.5 20.4 21.6 ±8.2 17.3 0.01*
Metabolic ratio Mean ratio
a s.d. Mean ratio
a s.d. P-value
Acetate/butyrate 2.78:1 ±0.83 3.10:1 ±0.75 0.39
Acetate/propionate 3.64:1 ±0.75 3.40:1 ±0.80 0.35
Butyrate/propionate 1.25:1 ±0.64 1.14:1 ±0.28 0.53
Total SCFA/acetate 1.77:1 ±0.19 1.65:1 ±0.13 0.05
Total SCFA/butyrate 4.38:1 ±1.02 5.03:1 ±0.88 0.06
Total SCFA/propionate 5.36:1 ±1.43 5.54:1 ±0.93 0.67
Abbreviations: HPLC, high-pressure liquid chromatography; SCFA, short-chain fatty acid; s.d., standard deviation.
aData are mean values calculated for fecal samples
of each group (obese: n¼15; normal-weight: n¼15). Mean SCFA concentrations that are significantly different between obese and normal-weight children are
denoted by *Po0.05.
Table 5 Intermediate metabolite concentrations of fecal samples from obese
and normal-weight children assessed by HPLC
Metabolite Obese Normal-weight P-value
mM
a s.d. mM
a s.d.
Lactose 0.01 ±0.04 0.07 ±0.17 0.15
Glucose 4.28 ±5.23 26.61 ±61.73 0.11
Lactate 0.80 ±0.77 12.02 ±14.3 0.009*
Formate 1.22 ±4.73 0.24 ±1.12 0.44
Isobutyrate 7.87 ±2.7 3.11 ±2.11 0.0007*
Isovalerate 2.33 ±2.45 3.05 ±2.33 0.38
Valerate 0.97 ±1.27 2.09 ±1.56 0.02*
Abbreviations: HPLC, high-pressure liquid chromatography; s.d., standard
deviation of the means.
aData are mean values calculated for fecal samples of
each group (obese: n¼15; normal-weight: n¼15). Intermediate metabolite
concentrations that are significantly different are denoted by *Po0.05.
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normal-weight adult subjects, although the cause and
consequence of these results and its relationship to obesity
remain unclear.
11 Analysis of fecal metabolites in this study
identified a tendency of obese gut microbiota in producing
higher levels of SCFA as previously reported. Significantly
higher levels of butyrate were detected in obese children,
despite similar acetate concentrations observed in each
group (Table 4). Multiple pathways dedicated to butyrate
production are enzymatically catalyzed through various
mechanisms specific to butyrate-producing species in the
large intestine. Conversion of acetate to butyrate, catalyzed
by butyryl coA/acetate coA transferase, represents the major
pathway for butyrate production.
28 The similar acetate/
butyrate ratio in obese and normal-weight children indicates
that more efficient conversion of acetate to butyrate is
not the likely predominating mechanism responsible for
increased butyrate concentrations in obese children. Buty-
rate kinase activity represents a second possible mechanism
for butyrate production, although distribution of the
butyrate kinase gene is more taxonomically restricted,
predominately present in members of clostridia.
28 Little
information exists regarding regulation of butyrate-produ-
cing pathways in gut microbiota, suggesting that the
increased concentrations of butyrate detected in obese
children could be a function of differential induction and
utilization of butyrate-producing pathways.
A third putative route of butyrate production involves
conversion of lactate by lactate-utilizing butyrate-producing
bacteria. This activity has been reported in clostridial cluster
XIVa species Eubacterium hallii and Anaerostipes caccae but is
absent from R. intestinalis and E. rectale.
29 Lactate is the major
fermentation product of lactic acid bacteria, including
lactobacilli, streptococci and enterococci and bifidobacteria,
although lactate production has also been reported in strict
anaerobes related to Eubacterium spp.
30,31 Despite the many
species capable of intestinal lactate production, lactate is
normally not detected in feces. The presence of lactate in
normal-weight, but not obese children, and significantly
higher concentrations of butyrate in obese children suggests
further the presence of lactate-utilizing butyrate-producing
species in obese children (Tables 4 and 5). It is unlikely that
the lactate detected in normal-weight feces was a result of
intestinal disease as no subjects reported any abnormal
gastrointestinal functioning.
A further possible route of lactate consumption involves
oxidation by SRB to produce H2S. SRB were demonstrated to
effectively compete with lactate-utilizing butyrate producers
in in vitro fermentations.
32 SRB were not significantly
different between obese and normal-weight children; how-
ever, individual populations demonstrated the highest
variation of any bacterial population tested (Table 3). SRB
populations in both healthy and ulcerative colitis patients
were also not significantly different, although total viable
SRB counts have been correlated to the severity of the
disease.
33,34 Lactate metabolism by SRB generates H2 as an
electron sink during abundant substrate concentrations.
High colonic H2 partial pressure inhibits fermentation by
preventing regeneration of NADH via the action of NADH/
ferredoxin oxidoreductase and hydrogenase. Reduction of
H2 partial pressure in the intestine is crucial for sustaining
fermentative processes and is facilitated by oxidation during
methanogenesis, acetogenesis, but also during dissimilatory
sulfate reduction as SRB may utilize both endogenously
produced and exogenous H2 as electron donor. The indivi-
dual nature of SRB viability and to what extent this may
potentially impact enteric metabolic function, warrants
further investigation.
Significantly higher levels of propionate were also identi-
fied in obese children (Table 4). Propionate-producing
species are more restricted in taxonomic distribution in
comparison with the abundance of butyrate-producing
species, with two major pathways for propionate production
having been described. Members of the Gram-negative
Bacteroides–Prevotella group produce propionate via succinate
or fumarate, whereas Gram-positive species of clostridial
cluster IX convert lactate to propionate via the acrylate
pathway.
35,36 In vitro analysis of lactate metabolism during
fermentation revealed it is primarily converted to butyrate
and not propionate.
37 Thus, it is unlikely that the depletion
of lactate observed in obese children significantly contrib-
uted to the higher propionate concentrations. Neither
succinate nor fumarate were measured in this study, thus,
the contribution of propionate formed via this pathway
cannot be determined.
In vitro gut fermentation modeling of obese and normal-
weight child microbiota presents a possible route for
distinguishing endpoint metabolic measurements from
active metabolism. We are currently evaluating multiple
in vitro gut fermentation models using obese and normal-
weight microbiota to better elucidate factors determining
microbial metabolic activity. As the metabolic fate of acetate,
butyrate and propionate has a profound effect on human
health, understanding the exact mechanisms governing
their production to better modulate enteric metabolite levels
is needed. Several studies have effectively demonstrated
significant differences between groups using cohorts similar
in size, confirming our sample size as sufficiently large
enough to detect any significant differences between obese
and normal-weight communities had they existed.
4,38,39 Our
results suggest that a dysbiosis may be involved in the
etiology of childhood obesity. In turn, aberrant and over-
active metabolic activity within the intestine could dictate
survival or loss of individual microbial communities. This
hypothesis suggests that the increased Fimicutes/Bacteroidetes
ratio observed in obese adults could be a result of dysbiosis
arising from adaptation of individual microbial communities
to long-term metabolic dysfunction. Validation of this
hypothesis could be achieved by evaluating gut microbial
compositions and metabolite concentrations of adolescents,
the missing link between childhood and adult results.
Metabolic profiling using ‘top down’ systems biology
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adolescents and adults) could unravel the exact host (e.g.,
genotype and phenotype) and microbial (e.g., metatran-
scriptome) factors determining evolution of the ‘metabo-
type’ and to what extent the metabolome dictates
community structure. Such studies have been used to
investigate differences in drug development and are becom-
ing increasingly of interest in developing personalized
nutrition and healthcare.
40 To our knowledge, no studies
following obese children into adulthood have been per-
formed to monitor the changes in gut microbial populations
and metabolic activities in the same individual over time.
Our results present compelling evidence for the usefulness of
such studies in unraveling the cause and consequence
relationship between gut microbiota and obesity.
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